Advanced Inhalation Therapies Ltd. (AIT) has announced the completion of a successful financing round, in which it has raised $1.25 million. AIT is developing nitric oxide based treatments for infectious lung diseases. The company says the funds will be used for two clinical trials.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments